XENE

Neutral

Driehaus files Schedule 13G/A disclosing 4.87% in Xenon (XENE)

Driehaus Capital Management LLC has filed a Schedule 13G/A, reporting a 4.87% beneficial ownership stake in Xenon Pharmaceuticals Inc. (XENE). As of D...

Stock Titan 2 weeks ago 0

Neutral

Nan Fung Trinity HK Ltd. Buys 68,360 Shares of Xenon Pharmaceuticals Inc. $XENE

Nan Fung Trinity HK Ltd. raised its stake in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 43.1% in the 4th quarter, Holdings Ch...

thelincolnianonline 3 weeks ago 0